Age |
28 years old |
Gender |
Female |
Clinical features |
Palpitations, shortness of breath,
fatigue |
Time between COVID-19 infection and onset of symptoms |
6
weeks |
TSH before COVID |
2.119 mIU/L (0.34 –
5.6)
5 months before COVID
|
TSH after COVID |
<0.01 mIU/L (0.34–5.6) |
fT4 before COVID |
7.61 pmol/l (7.86 – 14.41) |
fT4 after COVID |
36.04 pmol/l (7.86–14.41) |
fT3 before COVID |
4.92 pmol/l (3.95 – 6.8) |
fT3 after COVID |
6.18 pmol/l (3.95 – 6.8) |
Thyroglobulin Antibodies (TGAb) before COVID |
19.2 IU/mL (normal less
than or equal to 115) |
Thyroglobulin Antibodies (TGAb) after COVID |
173 IU/ml (normal less
than or equal to 115) |
Thyrotropin Receptor Antibody (TRAb) after COVID |
31.7 IU/L (normal
less than 1.75) |
TPO Antibody (TPOAb) after COVID |
>1000 IU/ml (normal less
than 5.61) |
Thyroid Ultrasound |
Mild thyromegaly with heterogeneous and diffusely
hypervascular sonographic appearance |